Home  >  Products  >  Prasugrel Hydrochloride (2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone Hydrochloride; CS 747; Effient; LY 640315)

Prasugrel Hydrochloride (2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone Hydrochloride; CS 747; Effient; LY 640315)

Cat no: P5620


Supplier: United States Biological
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
A novel antiplatelet agent; it is a third-generation thienopyridine. Antiplatelet agent Prasugrel showed greater platelet inhibition and decreased incidence of ischemic events than Clopidogrel but may induce increased incidence of bleeding in patients. Method for Determining Identity: Proton NMR Spectroscopic and Mass Spectrometric Analysis Related Substances: Total(same/less than)1.0% Individual(same/less than)0.5% Loss on Drying: (same/less than)0.5% Residue on Ignition: (same/less than)0.1% Heavy Metals: (same/less than)0.002% Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at -20 degrees C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Toxicity and Hazards: Due to the potential danger associated with the use of some of United States Biological biochemicals, all products should be handled by qualified personnel only, trained in laboratory procedures, and familiar with potential hazards. Information is not available on the possible hazards of many experimental compounds. The absence of a warning must not be interpreted as indication of safety.
Catalogue number: P5620
Size: 100mg
Form: Supplied as a light yellow or off white crystalline powder.
Purity: ~90%
Alternative names: 2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone Hydrochloride; CS 747; Effient; LY 640315
References: 1. Von Beckerath, N., et al.: Circulation, 112, 2946 (2005). 2. Jernberg, T., et al.: Eur. Heart J., 27, 1166 (2006). 3. Farid, N., et al.: Drug Metab. Dispos., 35, 1096 (2007). 4. Farid, N., et al.: Clin. Pharmacol. Ther., 81, 735 (2007). 5. Jakubowski, J., et al.: J. Cardiovasc. Pharmacol., 49, 167 (2007). 6. Wiviott, S., et al.: N. Engl. J. Med., 357, 2001 (2007).

Get Quote

  • Best Price Guaranteed
  • Quick Response Time
  • Exclusive Promotions
Enquiry_down_arrow
United States Biological
Get a Quote Direct from
United States Biological

By submitting this form you agree to your details being passed to United States Biological for the purpose of generating the best quote*

Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave